News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
840,456 Results
Type
Article (86115)
Company Profile (702)
Press Release (753639)
Section
Business (232510)
Career Advice (4123)
Deals (39702)
Drug Delivery (127)
Drug Development (90874)
Employer Resources (195)
FDA (18049)
Job Trends (17304)
News (396089)
Policy (39676)
Tag
Academia (2982)
Alliances (56716)
Alzheimer's disease (1432)
Approvals (18001)
Artificial intelligence (271)
Bankruptcy (400)
Best Places to Work (12633)
Biotechnology (481)
Breast cancer (251)
Cancer (1916)
Cardiovascular disease (154)
Career advice (3524)
CAR-T (147)
Cell therapy (427)
Clinical research (72718)
Collaboration (752)
Compensation (392)
COVID-19 (2844)
C-suite (187)
Data (1736)
Diabetes (245)
Diagnostics (6848)
Earnings (95630)
Employer resources (166)
Events (128593)
Executive appointments (622)
FDA (19050)
Funding (672)
Gene therapy (299)
GLP-1 (788)
Government (5095)
Healthcare (20852)
Infectious disease (2976)
Interviews (811)
IPO (17772)
Job creations (5183)
Job search strategy (2860)
Layoffs (524)
Legal (10089)
Lung cancer (280)
Manufacturing (280)
Medical device (14532)
Medtech (14537)
Mergers & acquisitions (22309)
Metabolic disorders (660)
Neuroscience (1910)
NextGen: Class of 2025 (7677)
Non-profit (5077)
Northern California (2234)
Obesity (363)
Opinion (264)
Patents (187)
People (64853)
Pharmaceutical (143)
Phase I (22429)
Phase II (31580)
Phase III (23780)
Pipeline (815)
Postmarket research (3552)
Preclinical (10059)
Radiopharmaceuticals (265)
Rare diseases (373)
Real estate (7382)
Regulatory (26466)
Research institute (2651)
Resumes & cover letters (649)
Southern California (1933)
Startups (4284)
United States (20572)
Vaccines (732)
Weight loss (275)
Date
Today (90)
Last 7 days (891)
Last 30 days (3058)
Last 365 days (37424)
2025 (5996)
2024 (38138)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Arizona (248)
Asia (49810)
Australia (8780)
California (5225)
Canada (1784)
China (440)
Colorado (240)
Connecticut (260)
Europe (114136)
Florida (755)
Georgia (183)
Illinois (550)
Indiana (293)
Maryland (827)
Massachusetts (4089)
Michigan (225)
Minnesota (374)
New Jersey (1479)
New York (1481)
North Carolina (1008)
Northern California (2234)
Ohio (187)
Pennsylvania (1166)
South America (1649)
Southern California (1933)
Texas (777)
Utah (162)
Washington State (522)
There are 840,456 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
March 3, 2025
·
4 min read
Press Releases
PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
Expecting FDA approval of Ketamine in Q2-2025 Solving the shortage problem of Ketamine and unlocking its pharmaceutical potential
March 3, 2025
·
5 min read
Press Releases
Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference
March 3, 2025
·
4 min read
Phase III
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a chronic blood cancer taking the drug didn’t need to have their blood removed to bring down dangerously high hemocrit levels.
March 3, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Actio Biosciences Announces First Participant Dosed in Phase 1 Clinical Trial of ABS-0871, a Novel TRPV4 Inhibitor, for the Treatment of Charcot Marie Tooth Disease 2C
March 3, 2025
·
3 min read
Layoff Tracker
CRISPR, Cytiva Laying Off Employees
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
March 3, 2025
·
139 min read
·
BioSpace Editorial Staff
Pain
Lexicon to Advance Non-Opioid Painkiller Despite Mid-Stage Trial Failure
Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III trials before long.
March 3, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study
March 3, 2025
·
5 min read
Press Releases
Fresenius Continues Growth of Biosimilars Portfolio with the U.S. Availability of Otulfi® (ustekinumab-aauz)
March 3, 2025
·
13 min read
Press Releases
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 3, 2025
·
13 min read
1 of 84,046
Next
